C-reactive protein [aapp, imft]
Colorectal Adenoma [neop]
celecoxib [orch, phsu]
treatment [ftcn]
Inflammation [patf]
Measured [qlco]
Circulating [ftcn]
Inflammatory [ftcn]
Marker [clna]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Cardiovascular disease [dsyn]
Colorectal Cancer [neop]
conflicting [inbe]
Adenoma [neop]
prevention trial [resa]
celecoxib [orch, phsu]
anti inflammatory drug [phsu]
celecoxib [orch, phsu]
PREVENT [phsu]
Colorectal Adenoma [neop]
increases [ftcn]
cardiovascular events [fndg]
Examined [fndg]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Modified [ftcn]
Measured [qlco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Serum specimen [bdsu]
Provided [acty]
Study [mnob]
Entry [inpr]
Patients [podg]
In [qnco]
Adenoma [neop]
prevention trial [resa]
celecoxib [orch, phsu]
Patients [podg]
Stratified [qlco]
Low-Dose Aspirin [orch, phsu]
randomized [resa]
Receive [qlco]
treatment [ftcn]
placebo [topp]
mg% [qnco]
celecoxib [orch, phsu]
mg% [qnco]
celecoxib [orch, phsu]
Colonoscopies [diap]
Patients [podg]
Estimated [qnco]
Cumulative [qlco]
Adenoma [neop]
Patients [podg]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
mg/L [qnco]
Compared [acty]
Relative Risk [qnco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
mg/L [qnco]
Relative Risk [qnco]
>90 [qnco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
mg/L [qnco]
celecoxib [orch, phsu]
Adenoma [neop]
Patients [podg]
mg/L [qnco]
Compared [acty]
mg/L [qnco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Patients [podg]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Relative Risk [qnco]
cardiovascular events [fndg]
Compared [acty]
placebo [topp]
randomized [resa]
celecoxib 200 MG [clnd]
mg% [qnco]
Contrast [qlco]
Patients [podg]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
RRS [dsyn]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
celecoxib [orch, phsu]
CARDIOVASCULAR [bdsy]
toxicity [qlco]
Adenoma [neop]
celecoxib [orch, phsu]
Treatment Efficacy [qlco]
Patients [podg]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
subgroup [virs]
Favorable [qlco]
risk benefit [qlco]
Profile [lbpr]
celecoxib [orch, phsu]
Chemoprevention [topp]
prev [idcn]
RES [fndg]
AACR [pros]
